We are a consortium of nine partners under the coordination of Charité – Universitätsmedizin Berlin. Our consortium combines excellence in technical and medical machine learning development with the clinical expertise of three leading stroke hospital partners.

Additionally, our consortium benefits from the special expertise in the development of trustworthy AI, software design, and the translation of AI models to the clinical setting with focus on the regulatory process. By leveraging the available medical data and exploiting technological opportunities in the field of AI, and developing and validating trustworthy AI solutions to be implemented in the clinical workflow we are seeking to surpass the clinical state-of-the-art by making a significant and sustainable impact on the treatment of acute stroke that will improve patient survival, outcome and quality of life.